Comprehensive Approach to Obesity Management
Dr. Amin takes a holistic approach to supporting weight management, considering the underlying factors contributing to weight gain and metabolic health. Through personalized treatment plans, he addresses both the physical and psychological aspects to help patients achieve long-term success in their health journey.
Dual Training in Psychiatry and Medicine
With expertise in both psychiatry and internal medicine, Dr. Amin is uniquely qualified to address the complex relationship between mental health and weight management. He understands the challenges individuals face when dealing with co-existing conditions and offers compassionate care to support their journey towards improved health.
Improving Total Health and Well-Being
If you are interested in an evaluation for managing your mental health and co-existing weight management needs, we will focus on the following core areas (with or without weight loss medications). Dr. Amin adheres to these three pillars:
Biological
- Improve your eating habits
- Optimize sleep, sexual health
- Improve or initiate physical activity
Psychological
- Treat depression, anxiety or other co-existing psychiatric disorders
- Enhance self-esteem
Social
- Improve your interpersonal relationships
- Enhance your relationship with your work
- Optimize your relationship with self and improve your boundaries with others
Evidence-Based Weight Management Medications
Explore detailed information about FDA-approved medications Dr. Amin may utilize as part of your comprehensive biological treatment plan.
How it Works
Semaglutide is a GLP-1 receptor agonist. It mimics a naturally occurring hormone that targets areas of the brain that regulate appetite and food intake, helping you feel fuller longer and slowing gastric emptying.
Administration
Administered via a once-weekly subcutaneous (under the skin) injection.
Expected Clinical Results
Clinical trials show an average of 15% to 20% total body weight loss, depending on adherence to lifestyle modifications.
How it Works
Tirzepatide is a dual-action medication (both a GIP and GLP-1 receptor agonist). By working on two distinct hormone pathways, it synergistically decreases appetite and significantly improves how the body breaks down sugar and fat.
Administration
Administered via a once-weekly subcutaneous (under the skin) injection.
Expected Clinical Results
Clinical trials indicate robust efficacy, often yielding 15% to 20%+ total body weight loss.
How it Works
An oral GLP-1 receptor agonist that mimics a natural hormone to regulate appetite and slow gastric emptying. This is the pill formulation of the medication found in the Wegovy injection.
Administration
Taken as a daily oral pill. It must be taken on an empty stomach with a small sip of water, and you must wait at least 30 minutes before eating, drinking, or taking other medications.
Expected Clinical Results
Clinical trials indicate approximately 15% to 17% total body weight loss.
How it Works
A newly approved (April 2026), non-peptide oral GLP-1 receptor agonist. It activates GLP-1 pathways to reduce hunger and promote a feeling of fullness.
Administration
Taken as a daily oral pill. Unlike other oral GLP-1s, it offers the convenience of being taken at any time of day, with or without food or water restrictions.
Expected Clinical Results
Clinical trials show an average of 11% to 12.4% total body weight loss at the highest dose.
How it Works
This is a non-stimulant oral medication that combines two distinct drugs to target the reward center of the brain. It specifically helps to reduce overall hunger while controlling intense cravings and emotional eating impulses.
Administration
Taken as an oral pill, daily.
Expected Clinical Results
Clinical studies show an average of 5% to 10% total body weight loss.
How it Works
An oral medication combining a central nervous system stimulant (Phentermine) to decrease appetite with an anticonvulsant medication (Topiramate) that promotes a feeling of profound fullness and satiety.
Administration
Taken as an oral pill, daily.
Expected Clinical Results
Typically results in roughly 10% total body weight loss.
How it Works
A central nervous system stimulant that works primarily by decreasing appetite and hunger signals in the brain.
Administration
Taken as a daily oral pill, usually early in the day to prevent sleep disturbances. Typically prescribed for short-term use alongside diet and exercise.
Expected Clinical Results
Typically results in an average of 5% total body weight loss.
| Feature | Wegovy® (Injection) | Zepbound® (Injection) | Wegovy® Pill (Oral) | Foundayo™ (Oral) | Contrave® (Oral) | Qsymia® (Oral) | Phentermine (Oral) |
|---|---|---|---|---|---|---|---|
| Mechanism | GLP-1 Agonist | GIP & GLP-1 Agonist | GLP-1 Agonist | Non-Peptide GLP-1 | Reward Center Targeting | Stimulant + Satiety Promoter | CNS Stimulant |
| Administration | Weekly Injection | Weekly Injection | Daily Pill (Requires Fasting) | Daily Pill (No Fasting Req) | Daily Pill | Daily Pill | Daily Pill (Morning) |
| Average Weight Loss* | 15% - 20% | 15% - 20%+ | 15% - 17% | 11% - 12.4% | 5% - 10% | ~10% | ~5% |
*Note: Expected results vary by individual and require adherence to lifestyle modifications. This information is for educational purposes and does not replace a clinical medical consultation.
Contact Us Today
If you are struggling with obesity and related conditions, reach out to Dr. Amin for personalized medical management services.